Stay updated on Talque & Teclistamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talque & Teclistamab Combo in Myeloma Clinical Trial page.

Latest updates to the Talque & Teclistamab Combo in Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded IPDSharing, Outcome Measures, Arms and Interventions, Study Description, and Study Status sections to the study record. The version history shows 60 versions as of 2025-12-18.SummaryDifference0.4%

- Check17 days agoChange DetectedFooter updates include a new Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link; no core content or trial data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedA new 'Study Status' entry was added to the Record History on 2025-12-05 (version 59 from 2025-12-04).SummaryDifference0.2%

- Check38 days agoChange DetectedThe page footer's revision label changed from 'Revision: v3.3.1' to 'Revision: v3.3.2'.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page history shows an added Revision: v3.3.1 and a removed Revision: v3.2.0, indicating an update to the site’s record history display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedA new version (58) was added on 2025-11-07 with a Study Status update, and a notice about government funding was removed.SummaryDifference0.6%

Stay in the know with updates to Talque & Teclistamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talque & Teclistamab Combo in Myeloma Clinical Trial page.